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Oxidants are important human toxicants. Increased
intracellular free Ca21 may be critical for oxidant toxic-
ity, but this mechanism remains controversial. Further-
more, oxidants damage the endoplasmic reticulum (ER)
and release ER Ca21, but the role of the ER in oxidant
toxicity and Ca21 regulation during toxicity is also un-
clear. tert-Butylhydroperoxide (TBHP), a prototypical
organic oxidant, causes oxidative stress and an increase
in intracellular free Ca21. Therefore, we addressed the
mechanism of oxidant-induced cell death and investi-
gated the role of ER stress proteins in Ca21 regulation
and cytoprotection after treating renal epithelial cells
with TBHP. Prior ER stress induces expression of the
ER stress proteins Grp78, Grp94, and calreticulin and
rendered cells resistant to cell death caused by a subse-
quent TBHP challenge. Expressing antisense RNA tar-
geted to grp78 prevents grp78 induction sensitized cells
to TBHP and disrupted their ability to develop cellular
tolerance. In addition, overexpressing calreticulin, an-
other ER chaperone and Ca21-binding protein, also pro-
tected cells against TBHP. Interestingly, neither prior
ER stress nor calreticulin expression prevented lipid
peroxidation, but both blocked the rise in intracellular
free Ca21 after TBHP treatment. Loading cells with
EGTA, even after peroxidation had already occurred,
also prevented TBHP-induced cell death, indicating that
buffering intracellular Ca21 prevents cell killing. Thus,
Ca21 plays an important role in TBHP-induced cell
death in these cells, and the ER is an important regula-
tor of cellular Ca21 homeostasis during oxidative stress.
Given the importance of oxidants in human disease, it
would appear that the role of ER stress proteins in pro-
tection from oxidant damage warrants further
consideration.
Because we exist in an oxygenated atmosphere, oxygen rad-
icals and organic oxidants are arguably the most important
class of exogenous and endogenous human toxicants. Accord-
ingly, oxidant toxicity has been implicated in many disease
processes including ischemia reperfusion injury, aging, cancer,
and neurodegenerative diseases, to name only a few (1–4). An
important role for intracellular Ca21 in oxidant-induced cell
death has been suggested by some, and the subject has been
reviewed (5–10); yet this proposal remains controversial. On
the one hand, it has been suggested that an increase in free
Ca21 is nothing more than a late event associated with loss of
membrane integrity and does not contribute appreciably to
oxidant-induced cell killing (7–9). On the other hand, it has
been proposed that an early increase in intracellular free Ca21
exacerbates oxidative stress, damages mitochondria, activates
Ca21-dependent degradative enzymes, and disrupts the cy-
toskeleton, all of which play a central role in oxidant-induced
cell death (5, 10, 11). Thus, the contribution of Ca21 deregula-
tion to oxidant-induced cell death remains unclear.
In addition, in cases where Ca21 appears to be involved in
cell killing, the contribution of intracellular versus extracellu-
lar Ca21 is not clear (5, 10). The endoplasmic reticulum (ER)1
is the major intracellular Ca21 storage site (12, 13). The ER
Ca21 pool plays an important role in the folding and post-
translational processing of secreted and cell surface proteins
(14). ER chaperones, including Grp78/BiP (where Grp is named
for glucose-regulated protein), Grp94, calnexin, and calreticu-
lin, are Ca21 binding proteins (15–17) and regulate ER Ca21
accumulation and release (18–21). Inhibiting the ER Ca21-
ATPase with thapsigargin or adding ionophores releases the
ER Ca21 pool, blocks ER protein processing causing partially
folded proteins to accumulate, and activates transcription of
ER chaperone genes, e.g. grp78 and grp94 (21–24). Loss of ER
Ca21 also activates eIF2a kinases causing a general inhibition
of translation, effects that are attenuated by prior induction of
ER stress proteins (25–29). Overexpression of calreticulin and
Grp78, both of which are ER Ca21-binding proteins and chap-
erones, increases the capacity of intracellular Ca21 stores (20,
21) and prevents Ca21 toxicity (30, 31). Oxidants, sulfhydryl
active agents, and free radicals also inhibit Ca21-ATPases and
release Ca21 from the ER (32–36), suggesting that ER Ca21
could play a role in oxidant toxicity. Nonetheless, despite the
fact that the ER is the major intracellular Ca21 store, that ER
stress proteins regulate the ER Ca21 pool, and that increased
cellular free Ca21 may contribute to oxidant-induced cell kill-
ing, there is no direct evidence linking regulation of cellular
Ca21 by the ER to cell death after oxidant exposure.
Prior induction of ER chaperones imparts tolerance to the
translational block caused by ER Ca21 depletion and protects
against the toxicity of Ca21 ionophores and other toxic insults
(22, 37, 38). Protection depends in part on expression of grp78
and grp94 because preventing an increase in their expression
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sensitizes cells to injury (30, 31, 39, 40). Recently, we demon-
strated that increasing the expression of ER stress protein
genes protects renal epithelial cells against a subsequent chal-
lenge with the alkylating and acylating agents, iodoacetamide,
or nephrotoxic cysteine conjugates, respectively (31, 41). With
iodoacetamide, protection required grp78 induction and was
linked both to inhibition of lipid peroxidation and maintenance
of low intracellular free Ca21 (31). Furthermore, overexpres-
sion of calreticulin, an ER Ca21-binding chaperone that in-
creases ER calcium retention (19, 42, 43), also protected cells
from iodoacetamide toxicity (31). These and related studies (21)
indicate that control of intracellular Ca21 by the ER may be
important in preventing toxicant-induced cell death. However,
the possibility that ER stress proteins blocked oxidative stress
directly, thus preventing the rise in Ca21, could not be excluded
in these studies.
TBHP is a prototypical organic oxidant and has been used
extensively to study the role of Ca21 in oxidant-induced cell
death. TBHP treatment causes peroxidation of cellular lipids,
oxidation of glutathione, loss of protein thiols, release of ER
Ca21, a general increase in cytosolic free Ca21, a permeability
transition in the mitochondrial inner membrane, and lipid
peroxidation (36, 44–47). However, the role of these perturba-
tions in TBHP-induced cell death and in particular the role of
Ca21 remains unclear (5, 8, 9, 44). Our previous studies on the
ER stress response provided new insights into cell death in-
duced by alkylating and acylating agents (31). Therefore, we
examined the effect of ER stress on TBHP toxicity. The results
indicate that prior ER stress or overexpression of calreticulin
prevented TBHP-induced cell death and blocked the increase in
cellular Ca21. Notably, neither manipulation blocked lipid per-
oxidation pointing to a central role for Ca21 and regulation of
cellular Ca21 levels by the ER in oxidant-induced cell death.
MATERIALS AND METHODS
The acetoxymethyl esters of EGTA (EGTA-AM) was purchased from
Molecular Probes (Eugene, OR). Sigma provided the TBHP. Other
common chemical and cell culture reagents were obtained from com-
mercial sources.
LLC-PK1 cells were obtained from American Type Culture Collection
(Manassas, VA) at passage 195 and were used from passage 205–215.
LLC-PK1 cells expressing either an antisense grp78 construct (pkAS-
grp78 cells) or overexpressing calreticulin (pkCRT cells) as well as their
counterparts transfected with the same pcDNA3 based plasmid con-
taining no insert (pkNEO cells) were all selected for neomycin resist-
ance and cloned as described (31). Cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% FBS (com-
plete medium) as described (31). TBHP was added to Earle’s balanced
salt solution (EBSS), and cultures were treated with TBHP for 40 min
in EBSS. Following treatment, cells were washed with phosphate-
buffered saline and then returned to complete medium. An ER stress
response was produced by treating cells with DTTox (10 mM), A23187 (7
mM), thapsigargin (0.3 mg/ml), or tunicamycin (1.5 mg/ml) as described
(31).
Cell death was assessed by measuring the release of lactate dehy-
drogenase (LDH) into the medium (48). Formation of thiobarbituric
acid-reactive substances (TBARS) was used as a measure of lipid per-
oxidation (49). In general, cells selected for neomycin resistance alone,
i.e. pkNEO cells, may differ in their responsiveness to toxicant relative
to wild type LLC-PK1 cells, an effect that is likely to be due to the
selection process itself as noted before (50), and have slightly lower
levels of lipid peroxidation after TBHP treatment (see Table II). Intra-
cellular free Ca21 measurements were carried out using Fura-2 as
described (31). Briefly, cells were treated with TBHP and then loaded
with Fura-2 for 1 h, and the intracellular free Ca21 concentration was
determined using a spectrofluorometer.
Significant differences (p , 0.05) were determined using a one-way
analysis of variance followed by a Student-Newman-Keul’s test for
multiple comparisons. When analysis of variance was performed, letter
designations are used in the figures and tables to indicate significant
differences. Means designated with a common letter are not different,
but different letter designations indicate a significant difference from
other means. If more than one letter designation is shown, it indicates
that the mean is not different from other means with either letter
designation. As an example, means designated C and D are different
from each other, but neither is significantly different from a mean
designated CD.
RESULTS
Exposing cells to oxidants, including TBHP, increases cellu-
lar free Ca21 and causes lipid peroxidation (44, 48). To estab-
lish the temporal relationship between these events and cell
death in LLC-PK1 cells, we determined the time courses for all
three events following TBHP exposure (Fig. 1). Lipid peroxida-
tion increased within the initial TBHP treatment period (40
min) and continued to rise after TBHP removal. An increase in
cellular free Ca21 followed the increase in lipid peroxidation,
but both events preceded cell death, which occurred between 2
and 4 h. Adding antioxidants prevented the rise in Ca21 (data
not shown) as reported previously (44), suggesting that lipid
peroxidation contributes to the Ca21 increase. These temporal
relationships are consistent with the proposal that oxidative
stress preceded the rise in Ca21.
We next examined the effect of conditioning cells with prior
ER stress on TBHP-induced cell death. Prior treatment with
four different ER stress inducers, all of which activate expres-
sion of ER stress proteins in these cells (31), prevented cell
death caused by a subsequent TBHP pulse treatment (Table I).
However, with the exception of A23187, none of these agents
blocked lipid peroxidation, even though they blocked the rise in
cellular Ca21 that was observed 2 h after TBHP treatment. The
induction of grp78 and the protective effect of prior ER stress in
iodoacetamide toxicity are disrupted in pkASgrp78 cells by
forced expression of an 0.5-kilobase antisense grp78 construct
(31). Therefore, we tested the TBHP sensitivity of three pkAS-
grp78 clones relative to pkNEO cells that carry only the neo-
mycin resistance marker (Fig. 2). pkASgrp78 cells were more
sensitive to TBHP relative to pkNEO cells. Pretreating pkAS-
grp78 cells with ER stress inducers was less effective in pre-
venting TBHP toxicity compared with the pkNEO counter-
FIG. 1. Temporal dependence of lipid peroxidation, increased
cellular Ca21 and cell death. Cells were treated with TBHP (1 mM)
for 40 min in EBSS and then washed and returned to DMEM containing
10% FBS. The abscissa indicates the time when TBHP treatment was
initiated (240 min) or after cells were returned to DMEM (0 min). Lipid
peroxidation was determined by measuring formation of TBARS. Ca21
was determined by spectrofluorometry in cells loaded for 1 h with
Fura-2 immediately after TBHP treatment. The time delay due to
Fura-2 loading is accounted for in the Ca21 data shown; thus, the first
Ca21 data were collected 60 min after TBHP removal. Cell death was
measured by determining the release of LDH into the medium. The cell
death and TBARS data are the averages 6 the range of data from two
separate experiments. Standard deviations on the TBARS data were
smaller than the symbols for each data point. For the Ca21 determina-
tion, data points with standard deviation (240, 75, 90,and 120 min)
reflect the averages 6 the range of data from two separate experiments
(n 5 2). Two additional points were collected, one in each of the two
experiments (60 and 120 min), to further define the shoulders on the
curve.























parts. A23187 was again the exception. Thus, the ability of
prior ER stress to prevent TBHP toxicity depended on expres-
sion of ER chaperones.
Previously we found that pkCRT cells, which overexpress the
ER chaperone and calcium binding protein calreticulin, were
also resistant to iodoacetamide damage (31). Therefore, we
evaluated their response to TBHP toxicity (Table II). pkCRT
cells were also less sensitive to TBHP compared with pkNEO
cells, and the protection correlated with maintenance of low
intracellular free Ca21 2 h after TBHP treatment, but at the
same time, lipid peroxidation was unaffected. Therefore, in-
creasing the ER chaperone content by two separate mecha-
nisms, prior ER stress or forced expression of calreticulin,
attenuated cell death and the increase in cellular free Ca21
after TBHP treatment without affecting lipid peroxidation.
If Ca21 is important in TBHP toxicity, then loading cells with
EGTA should prevent TBHP toxicity. However, EGTA may
chelate iron, thus making it difficult to separate effects on Ca21
from interference with iron-dependent Fenton generation of
free radicals (51, 52). To get around this problem, we exploited
the time difference between lipid peroxidation (early) and the
increase in Ca21 (later). Cells were treated with TBHP, then
washed, and returned to medium containing the cell-permeable
form of EGTA, EGTA-AM. Under these conditions, the majority
of the peroxidation had already occurred; yet adding EGTA-AM
still prevented cell death (Table III). There was only a modest,
albeit significant, effect on lipid peroxidation, an effect that is
probably associated with the decrease in cell death because in
these experiments lipid peroxidation was measured at 6 h, a
time when maximal cell death had already occurred. Thus the
EGTA experiments further support a role for Ca21 in TBHP-
induced cell death.
DISCUSSION
These studies provide the first evidence that ER stress pro-
teins protect cells from organic oxidants and provide new in-
sights into the roles of lipid peroxidation and intracellular free
Ca21 and ER Ca21 handling in cell killing. When taken in
context with prior literature (22, 31, 37), it appears that the
role of ER stress proteins in cytoprotection can now be gener-
alized to several distinct classes of toxicants and multiple path-
ways of cell death. In addition, preventing Ca21 disturbances
during cell injury may be a general mechanism underlying the
ability of the ER to protect against toxicants. This hypothesis is
in general agreement with the observations that ER stress
protects against Ca21 ionophore toxicity and that the stressed
ER is able to accumulate an increased load of Ca21 (21, 30, 40,
53). Notably, ER stress also prevents apoptosis induced by
iodoacetamide and thapsigargin,2 indicating that protection by
ER stress can be extended to multiple pathways of cell death.
By inducing ER stress proteins, we were also able to disso-
ciate lipid peroxidation from TBHP toxicity by preventing the
2 B. van de Water, H. Liu, E. Miller, and J. L. Stevens, unpublished
data.
TABLE I
ER stress blocks cell death and Ca21 perturbations but not lipid
peroxidation following TBHP treatment
Control cells or cells conditioned with DTTox, A23187, thapsigargin,
or tunicamycin to cause ER stress were treated with TBHP (1 mM) for
40 min, then washed, and returned to DMEM plus 10% FBS. Intracel-
lular free Ca21 was determined 2 h after removal of TBHP. TBARS
were measured before washing the cells and then again 2 h later as an
index of lipid peroxidation. The values shown are nmol/well from cells
cultured in 6-well dishes and are the sum of the TBARS that accumu-
lated during the TBHP treatment and that which accumulated during
the 2-h recovery period (see Fig. 1). Cell death was determined by
measuring LDH release 6 h after removal of TBHP. There was no LDH
release during the 40-min TBHP treatment. The data represent the
means 6 S.D. of data from three independent experiments (n 5 3).
Significant differences (p , 0.05) among the means were determined by
a one-way analysis of variance with multiple comparisons using the
Student-Neuman-Keul’s test and are indicated by different letters (see
“Materials and Methods”).
Inducer TBHP [Ca21] TBARS Cell Death
nM nmol %
None 2 44 6 11a 0.2 6 0.1a 0.7 6 0.9a
None 1 281 6 6b 3.9 6 0.2b 54 6 3b
DTTox 1 82 6 35a 3.1 6 0.2b 6.4 6 0.7a
A23187 1 109 6 22a 1.9 6 0.5c 2.1 6 3a
Thapsigargin 1 64 6 17a 3.2 6 0.1b 10 6 7a
Tunicamycin 1 138 6 68a 3.5 6 0.3b 23 6 2c
FIG. 2. pkASgrp78 cells are more sensitive to TBHP and do not
develop tolerance. The pkASgrp78 cells, which express a 0.5-kilobase
antisense grp78 construct, and their pkNEO counterparts were treated
with EBSS or TBHP (1 mM) in EBSS for 40 min with or without prior
induction of ER stress with A23187, the oxidized form of dithiothreitol
(DTTox), tunicamycin (TUNC),or thapsigargin (THAPS) as described
under “Materials and Methods.” Cells were returned to DMEM with
10% FBS after TBHP cell death was determined 6 h later. The data are
the means 6 S.D. of data collected from three separate pkNEO clones
and three separate pkASgrp78 clones of LLC-PK1 cells (n 5 3). Signif-
icant differences (p , 0.05) among means within the pkNEO or pkAS-
grp78 treatment groups were determined separately by a one-way anal-
ysis of variance with multiple comparisons using the Student-Neuman
Keul’s test and are indicated by different letters (uppercase for pkNEO
cells, and lowercase for pkASgrp78 cells; see “Materials and Methods”).
However, the pkASgrp78 cells were significantly more sensitive (p ,
0.05) to TBHP treatment compared with the pkNEO cells when all the
means from both the pkNEO and pkASgrp78 treatment groups were
analyzed together by a one-way analysis of variance (not shown).
TABLE II
Overexpression of calreticulin blocks cell death and Ca21 disturbances
but not lipid peroxidation
Three separate clones of pkCRT cells and pkNEO cells were treated
with TBHP (1 mM) for 40 min. Immediately following treatment, cells
were washed and returned to DMEM plus 10% FBS. Intracellular free
Ca21 was determined 2 h after washing the cells. TBARS, as a measure
of lipid peroxidation, and LDH release, as a measure of cell death, were
determined as indicated under “Materials and Methods” and the legend
to Table I. In general, TBARS levels are lower after TBHP treatment in
cells that have been selected for neomycin resistance (see “Materials
and Methods”). The data are the means 6 S.D. of the values for each
parameter determined for the three individual clones (n 5 3). Signifi-
cant differences were determined using a one-way analysis of variance
with the Student-Neuman-Keul’s test for multiple comparisons (p ,
0.05) and are indicated by different letters (see “Materials and Meth-
ods”).
Cells Treatment [Ca21] TBARS Cell death
nM nmol %
pkCRT none 48 6 5a 0.04 6 0.01a 4 6 1a
pkCRT TBHP 95 6 7a 1.94 6 0.16b 21 6 2b
pkNEO none 45 6 9a 0.01 6 0.01a 3 6 2a
pkNEO TBHP 219 6 59b 2.24 6 0.05b 55 6 7c























Ca21 disturbance. Importantly, this was accomplished without
pharmacological agents, which have ancillary effects, such as
iron chelation or antioxidant properties (52). TBHP causes an
early accumulation of oxidized glutathione, due to TBHP me-
tabolism (51), and lipid peroxidation, due to radical formation,
both of which precede the increase in cellular free Ca21 (44, 47,
48, 54). Both TBHP metabolism to radical species and/or accu-
mulation of oxidized glutathione can damage Ca21-ATPases in
the plasma membrane and the endoplasmic reticulum, dis-
abling the major cellular Ca21 buffering systems and allowing
intracellular Ca21 to increase (34, 36, 54–57). Thus, oxidative
stress and lipid peroxidation are upstream events that initiate
the rise in Ca21. Because an ER stress response blocks the
Ca21 increase downstream of the oxidant stress, cell death is
prevented without an effect on lipid peroxidation caused by
TBHP. Although we do not know the mechanisms coupling
increased Ca21 to cell death, there are several clear possibili-
ties including induction of a permeability transition in the
mitochondrial inner membrane and collapse of the membrane
potential (45, 46, 58–60), activation of degradative enzymes
such as phospholipases and proteases (10), and further stimu-
lation of oxidant production (61, 62), all of which occur after
TBHP treatment. This mechanism could differ with much
higher concentrations of TBHP or in other cell types but pro-
vides a reasonable explanation for the observations reported
here and elsewhere. Importantly, ER stress fits neatly into this
model because ER chaperones contribute to Ca21 buffering by
the ER (21), the major intracellular Ca21 storage site.
This mechanism resembles the model suggested for iodoa-
cetamide injury with an important exception; after iodoacet-
amide treatment, lipid peroxidation is a late event relative to
the increase in Ca21 and is blocked by prior ER stress (31, 48).
Unlike TBHP, iodoacetamide is not an oxidant per se but in-
duces lipid peroxidation after depletion of glutathione, loss of
protein thiols, and increased cellular free Ca21 (31, 48, 63).
Consequently, ER stress blocks lipid peroxidation after iodoa-
cetamide treatment because it prevents the rise in Ca21, that
is, in conjunction with the loss of glutathione, necessary to
cause lipid peroxidation. Thus, in the iodoacetamide and TBHP
models different primary events initiate the Ca21 increase, i.e.
thiol depletion in the case of iodoacetamide and free radical
production in the case of TBHP, accounting for the difference in
the effect of ER stress on lipid peroxidation in the two models.
To our knowledge, this is the first report that calreticulin
plays a role in protection against oxidant toxicity. Cells that
overexpress calreticulin have increased ER Ca21 buffering ca-
pacity and/or resist Ca21 toxicity (18–20, 31). Thus, the pro-
tective effect of calreticulin may be due to better ER Ca21
buffering, decreased Ca21 release, or an indirect mechanism
involving cooperation between Ca21 uptake by the ER and/or
extrusion across the plasma membrane. Elucidating the mech-
anism whereby calreticulin expression prevents Ca21 distur-
bances during injury may provide novel insights into general
mechanisms of cellular Ca21 handling during stress. In this
regard, it is interesting to note that calreticulin is also induced
by thapsigargin treatment and protects cells from thapsigar-
gin-induced apoptosis.3
The results with A23187 are also worth noting. A23187,
ionomycin, and thapsigargin are all used to perturb cellular
Ca21 and induce ER stress. Clearly, A23187 differs from the
other agents used in this study because treatment with A23187
prevented lipid peroxidation and protected pkASgrp78 cells. If
Ca21 ionophore toxicity induces oxidative stress, A23187 treat-
ment may also induce cellular antioxidant defense proteins, in
addition to activating ER stress response genes. Because anti-
oxidants block TBHP-induced cell death in LLC-PK1 cells (48),
activating antioxidant defense systems would be expected to
protect cells.
In conclusion, these studies highlight the importance of Ca21
and the ER stress response in oxidant-induced cell injury. The
results could have broad implications in our understanding of
how cells exploit an ER stress response to prevent cell injury.
For example, a defect in this type of endogenous protective
response could, in conjunction with defects in other antioxidant
defense systems or an increase in oxidative stress (1–4), pre-
dispose cells and organs to injury. In this regard, it has already
been shown that cells from aging rats are less able to up-
regulate expression of heat shock proteins relative to their
younger counterparts (64). Given the importance of oxidants in
human disease, it would seem that further investigation of the
role of molecular stress responses in regulating oxidative injury
is warranted.
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